The RAL Enigma: Distinct Roles of RALA and RALB in Cancer

Cells. 2022 May 14;11(10):1645. doi: 10.3390/cells11101645.

Abstract

RALA and RALB are highly homologous small G proteins belonging to the RAS superfamily. Like other small GTPases, the RALs are molecular switches that can be toggled between inactive GDP-bound and active GTP-bound states to regulate diverse and critical cellular functions such as vesicle trafficking, filopodia formation, mitochondrial fission, and cytokinesis. The RAL paralogs are activated and inactivated by a shared set of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) and utilize similar sets of downstream effectors. In addition to their important roles in normal cell biology, the RALs are known to be critical mediators of cancer cell survival, invasion, migration, and metastasis. However, despite their substantial similarities, the RALs often display striking functional disparities in cancer. RALA and RALB can have redundant, unique, or even antagonistic functions depending on cancer type. The molecular basis for these discrepancies remains an important unanswered question in the field of cancer biology. In this review we examine the functions of the RAL paralogs in normal cellular physiology and cancer biology with special consideration provided to situations where the roles of RALA and RALB are non-redundant.

Keywords: GTPases; RAL; RALA; RALB; RALBP1; RAS; cancer; endocytosis; exocytosis.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Cell Survival
  • GTPase-Activating Proteins / metabolism
  • Humans
  • Monomeric GTP-Binding Proteins* / metabolism
  • Neoplasms*
  • ral GTP-Binding Proteins / genetics
  • ral GTP-Binding Proteins / metabolism

Substances

  • GTPase-Activating Proteins
  • Ralb protein, human
  • RALA protein, human
  • Monomeric GTP-Binding Proteins
  • ral GTP-Binding Proteins

Grants and funding

This work was supported by the United States of America Department of Defense CDMRP Breast Cancer Research Program (W81XWH-20-1-0047, S.T.S.).